Clinical Trials Directory

Trials / Completed

CompletedNCT05096676

Understanding Oxytocin's Neural and Behavioral Effects in Adolescents Diagnosed With Autism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Prof. Ilanit gordon · Academic / Other
Sex
Male
Age
12 Years – 18 Years
Healthy volunteers
Accepted

Summary

The investigators explored the neural and behavioral effect of oxytocin on youth with Autism spectrum disorder using magnetoencephalography (MEG). The investigators hypothesize that oxytocin will modulate neural activity to resemble patterns observed in the age-matched control group. Thirty-two adolescents with autism and 26 typically developing adolescents participated in this randomized, double-blind MEG study. Individuals with autism arrived at the lab twice and received an acute dose of intranasal oxytocin or placebo in each session. During the scans, participants were asked to complete several tasks related to social perception - such as identification of social and non-social stimuli.

Detailed description

In the current study, the investigators aimed to explore oxytocin's influences on neural components that relate to social processing. Namely, we focused on M100, M170, and M250, which tend to show atypical patterns in individuals with autism. The investigators also examined the effects of oxytocin on time dynamics - the change in specific oscillation over time and its effects on neural connectivity patterns.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin: Including placeboIndividual received age-dependent dosing of oxytocin and placebo. Participants aged 13-18 years received a dose of 24 IU (3 puffs to each nostril), and younger participants (aged 12 years) received 16 IU.

Timeline

Start date
2016-08-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2021-10-27
Last updated
2021-10-27

Source: ClinicalTrials.gov record NCT05096676. Inclusion in this directory is not an endorsement.